A consensus-based approach to GDP lies at the heart of a new industry-wide program seeking to rationalize, standardize, and harmonize the adherence to pharma transportation norms and regulatory guidelines.
Courtney Soulsby
Advertisement
Courtney Soulsby is sector director, Healthcare & Life Sciences, BSI.
Articles by Courtney Soulsby
Advertisement
Latest Updated Articles
A New Route to Pharma GDP Compliance and StandardizationMarch 2nd 2022
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Improving Oral Peptide Delivery Through Structural Modifications
2
Potent APIs Amplify Carryover Risk: AAPS PharmSci 360 2026
3
Regulatory Roundup—October 2026: FDA Advances Rare Disease Development and Transparency Efforts
4
Using OEE Monitoring to Justify Expenditure on Aging Production Lines
5